Jordi Rubiralta (#2741)
- $ 1 B
- Diagnostics
- Spain
- M
- 52 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Jordi Rubiralta derives his fortune from Werfen, a diagnostics company based in Madrid. Founded by his late father Josep María Rubiralta and uncle Francisco in 1966, today the company covers diagnostics in hemostasis, acute care, transfusion, autoimmunity and transplants. Rubiralta chaired the company until 2019 but remains on the board. He led the expansion of Werfen in Germany and the U.S. with the acquisition of Tem and Accriva Diagnostics. Rubiralta's family office, Yukon Capital, has carried out some of the most high-profile real estate transactions in Spain in recent years.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Jordi Rubiralta’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Jordi Rubiralta’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.4B
(May 4, 2026)
© Iconic Billionaires